On 21 September 2016, world leaders made a commitment to work at national, regional, and global levels to address the growing threat of antimicrobial resistance (AMR).
The Biochemical Society is a member of the Learned Society Partnership on Antimicrobial Resistance (LeSPAR), who released the following statement:
“The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) welcomes news of global political and pharmaceutical industry support for actions to tackle the threat of resistant infections.
The G7 and G20 summits and the UN General Assembly have now agreed proactive steps to ensure collaboration between nations, accepting the recommendations of the WHO Global Action Plan on AMR and the UK AMR Review. In particular they have agreed:
- Support for all countries to design and implement national action plans
- Initiatives to stimulate research and development of new antimicrobial products
- Public awareness and engagement activities
In line with these agreements, the pharmaceutical industry has published a roadmap with an emphasis on public-private partnership. This guides both the development of new drugs and the management of access to antimicrobials, where and when they are needed.
LeSPAR will continue to work with our collective community of experts to ensure actions are taken in support of these resolutions.”
You can find out more about LeSPAR here.